Your browser doesn't support javascript.
loading
Plasma IL-6 levels and their association with brain health and dementia risk: A population-based cohort study.
Zhao, Zhengyang; Zhang, Jiashuo; Wu, Yulu; Xie, Min; Tao, Shiwan; Lv, Qiuyue; Wang, Qiang.
Afiliación
  • Zhao Z; Mental Health Center, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Zhang J; Mental Health Center, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Wu Y; Mental Health Center, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Xie M; Mental Health Center, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Tao S; Mental Health Center, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Lv Q; Mental Health Center, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Wang Q; Mental Health Center, West China Hospital of Sichuan University, Chengdu, Sichuan, China. Electronic address: wangqiang130@scu.edu.cn.
Brain Behav Immun ; 120: 430-438, 2024 Aug.
Article en En | MEDLINE | ID: mdl-38897328
ABSTRACT

BACKGROUND:

Recent studies have associated immune abnormalities with dementia. IL-6 is a crucial cytokine in inflammatory responses, and recent evidence has linked elevated IL-6 levels to changes in brain structure and cognitive decline. However, the connection between IL-6 levels, cognition, brain volumes, and dementia risk requires exploration in large prospective cohorts.

METHODS:

This study utilized a longitudinal cohort from the UK Biobank to analyze the correlation between IL-6 expression levels, cognitive performance, and cortical and subcortical brain volumes through linear regression. Additionally, we assessed the association between IL-6 levels and long-term dementia risk using Cox regression analysis. We also used one-sample Mendelian randomization to analyze the impact of genetic predisposition of dementia on elevated IL-6 levels.

RESULTS:

A total of 50,864 participants were included in this study, with 1,391 new cases of all-cause dementia identified. Higher plasma IL-6 levels are associated with cortical and subcortical atrophy in regions such as the fusiform, thalamus proper, hippocampus, and larger ventricle volumes. IL-6 levels are negatively associated with cognitive performance in pair matching, numeric memory, prospective memory, and reaction time tests. Furthermore, elevated IL-6 levels are linked to a 23-35 % increased risk of all-cause dementia over an average follow-up period of 13.2 years. The one-sample Mendelian randomization analysis did not show associations between the genetic predisposition of dementia and elevated IL-6 levels.

CONCLUSIONS:

Increased IL-6 levels are associated with worse cognition, brain atrophy, and a heightened risk of all-cause dementia. Our study highlights the need to focus on the role of peripheral IL-6 levels in managing brain health and dementia risk.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / Interleucina-6 / Demencia Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Brain Behav Immun Asunto de la revista: ALERGIA E IMUNOLOGIA / CEREBRO / PSICOFISIOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / Interleucina-6 / Demencia Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Brain Behav Immun Asunto de la revista: ALERGIA E IMUNOLOGIA / CEREBRO / PSICOFISIOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos